2014. The year of the mega-merger that never was, the year Gilead launched the world’s most expensive medicine and turned it into a multibillion dollar blockbuster, the year we saw the first approval for a biosimilar, of immuno-oncology and the dawn of checkpoint inhibitors, of sex, lies and videotapes, and the year Apple and other technology giants showed pharma how to really shake up the healthcare space and move it into the 21st Century.
It’s also the year pharma and healthcare systems alike finally sat up and took notice of the most important part of the ecosystem: the patient.
For an industry still driven by a product-focused business model – and which all too often leaves the patient as an afterthought – engineering this revolutionary shift has posed a challenge of epic proportions.
While some companies are already pushing boundaries by allowing patients to sit in the driving seat in decisions about their care, others have work to do. So will 2015 be the year pharma truly ‘gets’ what it’s like to be a patient? (See our features on pages 25, 35 and 41).
On a personal level, this year has been one of huge transformation for everyone at PharmaTimes – we formed a new company, under new leadership, to house first the publications and then, in September, the competitions. With the publications going from strength to strength and the success of what’s widely acclaimed to be the best Marketer and Communications Team of the Year competition ever, I want to take this opportunity to thank all those who have helped guide, advise and support us in our new venture over the past months.
There’s a lot more to come from us, and we hope for you, in 2015. So we wish all our readers, finalists, sponsors, advertisers and partners a very happy and prosperous New Year.
To read the latest issue of PharmaTimes Magazine, sign up for a free digital subscription or download our free app via iTunes or Google play.